Seungju Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Seungju Kim has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Dong-Woo Choi
Cancer Data Center, National Cancer Center, Goyang-si, Republic of Korea
2 shared publicationsKyu-Tae Han
Division of Cancer Control and Policy, National Cancer Center, Goyang-si, Republic of Korea
2 shared publicationsAreum Song
Department of Preventive Medicine, Korea University College of Medicine, Seoul, Republic of Korea
1 shared publicationWoorim Kim
Division of Cancer Control & Policy, National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea
1 shared publicationYeong Jun Ju
Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon, Republic of Korea
1 shared publication
Latest Publications
- 26 May 2023
- Published by Elsevier in Primary Care Diabetes
- Vol. 17 (4) , 359-365
Relationship between lifestyle changes due to the COVID-19 pandemic and depression: Nationwide population-based research using Community Health Survey data in South Korea
- 26 May 2023
- Published by Elsevier in Primary Care Diabetes
- Vol. 17 (4) , 359-365
Relationship between lifestyle changes due to the COVID-19 pandemic and depression: Nationwide population-based research using Community Health Survey data in South Korea
- 16 August 2022
- Published by Elsevier in Primary Care Diabetes
- Vol. 16 (5) , 677-683
Effect of primary care-level chronic disease management policy on self-management of patients with hypertension and diabetes in Korea
- 16 August 2022
- Published by Elsevier in Primary Care Diabetes
- Vol. 16 (5) , 677-683
Effect of primary care-level chronic disease management policy on self-management of patients with hypertension and diabetes in Korea
- Open Access
- 21 October 2021
- Published by Springer Nature in BMC Geriatrics
- Vol. 21 (1) , 1-10
Regional and income disparities in treatment and drug adherence of patients with dyslipidemia: a retrospective cohort study in South Korea, 2003–2015
Backgrounds: Health disparities represent a major public health problem that needs to be addressed, and a variety of factors, including geographical location and income, can contribute to these disparities. Although previous studies have suggested that health differs by region and income, evidence on the difference in treatment rate is relatively insufficient. To identify differences in prescription rates by region and income in patients with dyslipidemia. Methods: Using data from the National Health Insurance Service senior cohort, we included older adults who were diagnosed with dyslipidemia in Korea from 2003 to 2015. Overall prescription rate was determined for patients with dyslipidemia. In addition, medication possession ratio and a defined daily dose were analyzed in patients who were prescribed statins. A generalized estimating equation Poisson model was used to assess differences in prescription rates. Results: Patients living in rural areas (Chungcheong-do, Jeolla-do, and Gyeongsang-do) had a significantly higher prescription rate than those in metropolitan cities. Unlike the prescription rate, the drug adherence was significantly higher in Seoul, Gyeonggi-do, and Gangwon-do but lower in Jeolla-do and Gyeongsang-do than in metropolitan cities. Patients with low income had lower prescription rates than those with high income, but this difference was not statistically significant. Conclusion: Our findings demonstrate differences in the treatment rates of patients with dyslipidemia by region and income. Appropriate interventions are needed in vulnerable regions and groups to increase the treatment rate for patients with dyslipidemia.
- 21 October 2021
- Published by Springer Nature in BMC Geriatrics
- Vol. 21 (1) , 1-10
Open AccessRegional and income disparities in treatment and drug adherence of patients with dyslipidemia: a retrospective cohort study in South Korea, 2003–2015
Backgrounds: Health disparities represent a major public health problem that needs to be addressed, and a variety of factors, including geographical location and income, can contribute to these disparities. Although previous studies have suggested that health differs by region and income, evidence on the difference in treatment rate is relatively insufficient. To identify differences in prescription rates by region and income in patients with dyslipidemia. Methods: Using data from the National Health Insurance Service senior cohort, we included older adults who were diagnosed with dyslipidemia in Korea from 2003 to 2015. Overall prescription rate was determined for patients with dyslipidemia. In addition, medication possession ratio and a defined daily dose were analyzed in patients who were prescribed statins. A generalized estimating equation Poisson model was used to assess differences in prescription rates. Results: Patients living in rural areas (Chungcheong-do, Jeolla-do, and Gyeongsang-do) had a significantly higher prescription rate than those in metropolitan cities. Unlike the prescription rate, the drug adherence was significantly higher in Seoul, Gyeonggi-do, and Gangwon-do but lower in Jeolla-do and Gyeongsang-do than in metropolitan cities. Patients with low income had lower prescription rates than those with high income, but this difference was not statistically significant. Conclusion: Our findings demonstrate differences in the treatment rates of patients with dyslipidemia by region and income. Appropriate interventions are needed in vulnerable regions and groups to increase the treatment rate for patients with dyslipidemia.
- 1 August 2021
- Published by Elsevier in Health Policy
- Vol. 125 (8) , 1047-1053
Is time-to-treatment associated with higher mortality in Korean elderly lung cancer patients?
- 1 August 2021
- Published by Elsevier in Health Policy
- Vol. 125 (8) , 1047-1053
Is time-to-treatment associated with higher mortality in Korean elderly lung cancer patients?